<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>105(1)</volume><submitter>Ye J</submitter><pubmed_abstract>Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a membrane-bound serine protease inhibitor that is expressed on the surface of epithelial and carcinoma cells. On the cell surface, HAI-1 regulates membrane-anchored serine proteases, with matriptase being the most critical target. Matriptase is involved in pericellular processing of biologically active molecules, including protease-activated receptor-2 (PAR-2). Previously we reported that S2-CP8 cells, a metastatic variant of the SUIT-2 human pancreatic adenocarcinoma cell line, showed markedly decreased HAI-1 expression. To assess the significance of HAI-1 loss in invasion and spontaneous metastasis of S2-CP8 cells, we established stable S2-CP8 sublines that expressed HAI-1 under the control of a tetracycline-regulated promot</pubmed_abstract><journal>Cancer science</journal><pagination>44-51</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4317873</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.</pubmed_title><pmcid>PMC4317873</pmcid><pubmed_authors>Kanemaru A</pubmed_authors><pubmed_authors>Kawaguchi M</pubmed_authors><pubmed_authors>Yamamoto K</pubmed_authors><pubmed_authors>Haruyama Y</pubmed_authors><pubmed_authors>Ye J</pubmed_authors><pubmed_authors>Fukushima T</pubmed_authors><pubmed_authors>Lin CY</pubmed_authors><pubmed_authors>Kataoka H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.</name><description>Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a membrane-bound serine protease inhibitor that is expressed on the surface of epithelial and carcinoma cells. On the cell surface, HAI-1 regulates membrane-anchored serine proteases, with matriptase being the most critical target. Matriptase is involved in pericellular processing of biologically active molecules, including protease-activated receptor-2 (PAR-2). Previously we reported that S2-CP8 cells, a metastatic variant of the SUIT-2 human pancreatic adenocarcinoma cell line, showed markedly decreased HAI-1 expression. To assess the significance of HAI-1 loss in invasion and spontaneous metastasis of S2-CP8 cells, we established stable S2-CP8 sublines that expressed HAI-1 under the control of a tetracycline-regulated promot</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Jan</publication><modification>2025-04-20T02:51:17.651Z</modification><creation>2019-03-27T01:44:40Z</creation></dates><accession>S-EPMC4317873</accession><cross_references><pubmed>24147538</pubmed><doi>10.1111/cas.12306</doi></cross_references></HashMap>